Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
C5orf56 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CASP10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MYCBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKCA-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFYVE26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLDN23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BATF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OCLN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APCDD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDH13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTSS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAPSS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD274 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPANXA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100129518 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TLR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on